Midomafetamine Completed Phase 2 Trials for Post Traumatic Stress Disorder (PTSD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03282123Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD
NCT01689740Randomized, Double-blind, Active-placebo Controlled Study of MDMA-assisted Psychotherapy in People With Chronic PTSD
NCT03485287Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD
NCT01211405Study Comparing Three Doses of MDMA Along With Psychotherapy in Veterans With Posttraumatic Stress Disorder
NCT01793610Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
NCT00353938Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
NCT00090064A Test of MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder